Tribio InVivoMAb Anti-Human CD79b & CD3 Bispecific Antibody (TBS10466)
$479.00 – $1,919.00
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBS10466-100 | Yes | 100 UG | $479.00 | |||
| TBS10466-1 | Yes | 1 MG | $1,919.00 |
- Description
- Terms
- Additional information
- Reviews (0)
Description
Description: Tribio CD79B & CD3 InVivoMAb Bispecific Antibody is a recombinant antibody designed to simultaneously target CD79B on B cells and CD3 on T cells, promoting T cell engagement and cytotoxic activity against CD79B-expressing B cells. It is commonly used in immuno-oncology research to study T cell–redirected B cell killing, immune synapse formation, and therapeutic strategies for B cell malignancies such as lymphomas.
Applications: FuncS
Species reactivity: Human
Host species: Human
Target: B-cell-specific glycoprotein B29, CD79B, B-cell antigen receptor complex-associated protein beta chain, Ig-beta, B29, Immunoglobulin-associated B29 protein, IGB, CD79b, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Isotype: IgG like Duobody
Accession/UniProt: P40259 & P07766
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage buffer: 0.01M PBS, pH 7.4
Purification: Protein A/G purified from cell culture supernatant.
Clonality: Monoclonal
Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.
Research use only.
Additional information
| SIZE (mg) | 1 MG, 100 UG |
|---|
Be the first to review “Tribio InVivoMAb Anti-Human CD79b & CD3 Bispecific Antibody (TBS10466)”
You must be logged in to post a review.
Reviews
There are no reviews yet.